| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is experiencing notable advancements in product development, particularly with the recent approval of Omvoh for Crohn’s disease and ongoing innovations in obesity treatment and cancer therapy. Their commitment to healthcare innovation is further demonstrated by the launch of a biotech ecosystem fund aimed at enhancing patient care. However, the company is facing challenges with slower-than-expected sales growth of weight-loss drugs, which has negatively impacted investor sentiment. Overall, the landscape of product and service development remains dynamic and promising for Eli Lilly. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.2 on 2025-01-16. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (1.8) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-16 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-01-10 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| 2024-12-11 | 0%(0%) | 0 | 0% | 0.2 | 2.1 | -1 | |||||||
| 2024-12-06 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2024-11-26 | 0%(0%) | 0 | 0% | 0.5 | 4.1 | -1 | |||||||
| 2024-11-19 | 0%(0%) | 0 | 0% | 0.5 | 4.1 | -1 | |||||||
| 2024-11-05 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2024-11-04 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2024-10-31 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2024-10-30 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:15:42 The introduction of new therapies like Omvoh signifies progress in healthcare and treatment options for patients with IBD. |
| 2025-05-19 17:15:42 Lilly's approval of Omvoh positions them favorably against competitors in the IBD therapy market. |
| 2025-05-19 17:15:42 The approval is expected to influence market dynamics within the inflammatory bowel disease treatment sector. |
| 2025-05-19 17:15:42 The expansion of Omvoh's use demonstrates advancements in product development for treating inflammatory bowel diseases. |
| 2025-05-19 17:15:42 The approval of Lilly's Omvoh by the FDA highlights the regulatory pathway's critical role in the pharmaceutical industry. |